|
|
|
|
|
|
|
|
|
|
Previous: PEDIATRIX MEDICAL GROUP INC, 10-Q, EX-10.39, 2000-11-14 |
Next: PEDIATRIX MEDICAL GROUP INC, 10-Q, EX-27.1, 2000-11-14 |
Exhibit 11.1
<TABLE>
<CAPTION>
STATEMENT RE: COMPUTATION OF PER SHARE EARNINGS
Three Months Ended Nine Months Ended
September 30, September 30,
--------------------------------- ---------------------------------
2000 1999 2000 1999
------------- ------------- ------------- -------------
(in thousands, except for per share data)
<S> <C> <C> <C> <C>
Basic:
Net income applicable to
common stock $ 3,829 $ 4,985 $ 6,916 $ 20,047
============= ============= ============= =============
Weighted average number of
common shares outstanding 15,779 15,502 15,727 15,438
============= ============= ============= =============
Basic net income per share $ .24 $ .32 $ .44 $ 1.30
============= ============= ============= =============
Diluted:
Net income applicable to
common stock $ 3,829 $ 4,985 $ 6,916 $ 20,047
============= ============= ============= =============
Weighted average number of
common shares outstanding 15,779 15,502 15,727 15,438
Weighted average number of
dilutive common stock equivalents 408 222 199 408
------------- ------------- ------------- -------------
Weighted average number of
common and common equivalent
shares outstanding 16,187 15,724 15,926 15,846
============= ============= ============= =============
Diluted net income per share $ .24 $ .32 $ .43 $ 1.27
============= ============= ============= =============
</TABLE>
|
|